Navigation Links
Researchers question key quality measure for asthma
Date:10/4/2011

AURORA, Colo. -- Researchers studying the first national quality measure for hospitalized children have found that no matter how strictly a health care institution followed the criteria, it had no actual impact on patient outcomes.

The scientists examined 30 hospitals with 37,267 children admitted for asthma from 2008 to 2010 and discovered that the quality of discharge planning made no difference to the rate of return to the hospital for another asthma attack in 7, 30 or 90 days.

"Our research concluded that there is no relationship between compliance with this measure and readmission rates for asthma patients," said study co-author Marion Sills, MD, MPH and associate professor of pediatrics at the University of Colorado School of Medicine.

The findings have been published in October's Journal of the American Medical Association (JAMA).

Asthma is the leading cause of admissions in children's hospitals. To help provide the best care, the Joint Commission, a non-profit that accredits and certifies more than 19,000 health care organizations programs nationwide, adopted three core process measures for evaluating how hospitals treat childhood asthma.

The Children's Asthma Care (CAC) measures include giving asthma relievers upon admission, providing systemic corticosteroids and creating a home management plan of care when they are discharged. Hospitals' compliance with the first two measures was high and did not vary enough for researchers to study the impact on outcomes.

By studying hospitals' compliance with the third measure -- devising a home health management plan -- researchers concluded that it had no effect on hospital readmissions or return emergency department visits for asthma.

"No matter how well your hospital did in complying with this there was no difference in readmissions," Sills said. "For a parent trying to choose a hospital for a child with an asthma attack, this quality measure doesn't help determine which hospital will provide better care. From a policy standpoint, these measures may not meet the Joint Commission's own criteria for an accountability measure -- that compliance should lead to better outcomes. This is especially important for measures that will be used for public reporting and pay for performance. Requiring a hospital to meet a certain criteria of patient care and then finding out that it makes no difference is reason to reevaluate these measures."

The findings are significant because until recently none of the more than 50 Joint Commission measures evaluated care for hospitalized children. They have been used for numerous other conditions with varying success. For example, acute myocardial infarction mortality rates decreased but congestive heart failure death rates did not during times when compliance with process measures increased.

Sills and the other researchers concluded by saying the Joint Commission should reconsider whether a hospital's compliance with the CAC measures is suitable for public reporting, accreditation or pay for performance.


'/>"/>
Contact: David Kelly
david.kelly@ucdenver.edu
303-315-6374
University of Colorado Denver
Source:Eurekalert

Related medicine news :

1. Researchers from Boston University receive grant to develop improved virus detection system
2. Researchers review studies on CCSVI-MS link
3. Researchers call for more awareness of male breast cancer as cases rise
4. Researchers transform iPhone into high-quality medical imaging device
5. Fox Chase researchers identifiy more accurate treatment delivery for robotic radiosurgery system
6. Georgia Tech researchers receive 3 NSF Emerging Frontiers awards
7. Childrens National researchers make breakthrough in understanding white matter development
8. UH researchers explain hormonal role in glucose and fat metabolism
9. Researchers identify enzyme that regulates degradation of damaged proteins
10. UTHealth researchers train promotoras to combine mobile technology, cancer prevention messages
11. Researchers uncover gene associated with blood cancers
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/28/2017)... ... April 28, 2017 , ... Yisrayl Hawkins, Pastor and Overseer at The House of Yahweh ... Creator responds to and which He does not. Yisrayl says with so many titles ... the true name, but he says with a little Scripture, backed with a lot of ...
(Date:4/28/2017)... ... ... Intellitec Solutions announced the publication of a case study ... solution that integrates to their PointClickCare EHR software package. With the guidance of ... now has the capability to achieve its goal for a comprehensive EHR solution, ...
(Date:4/28/2017)... ... ... Lowe is a popular actor that has been in many different movies and television ... host of the “Informed” series. The program focuses on many important issues that society ... thyroid cancer. , Although thyroid cancer is an uncommon type of cancer, people still ...
(Date:4/27/2017)... ... April 27, 2017 , ... Today, Jefferson ... in Denver, Colorado, announced an agreement to create the Jane and Leonard Korman ... the Jane and Leonard Korman Family Foundation. The collaboration leverages the strengths of ...
(Date:4/27/2017)... ... April 27, 2017 , ... Thinksport, ... the heels of Thinksport’s award-winning sunscreen they’ve used the same scientific approach to ... , Countless deodorants flood the aisles that contain harmful chemicals that should be ...
Breaking Medicine News(10 mins):
(Date:4/20/2017)... 20, 2017  Cogentix Medical, Inc. (NASDAQ: CGNT), ... the Urology, Uro/Gyn and Gynecology markets with innovative ... has joined the Company as Senior Vice President, ... position, Mr. Keswani will report directly to ... "Our organization is delighted that Ash has joined ...
(Date:4/20/2017)... Research and Markets has announced the addition of the ... Market and Increasing Usage of Complex Biologics during the Forecast Period" ... ... 20 Billion in 2015 to around USD 26 Billion by 2020. ... by Rapidly Expanding Injectables Market and Increasing Usage of Complex Biologics ...
(Date:4/20/2017)... , April 20, 2017 Eyevensys, ... the first non-viral gene expression technology that enables the ... eye to address a wide range of ophthalmic diseases, ... and Healthcare products Regulatory Agency (MHRA) to advance its ... ...
Breaking Medicine Technology: